• BioTime Announces Issuance of US Patent for Method of Reducing Cavitation in Patients with …

    ALAMEDA, Calif.–(BUSINESS WIRE)–May 6, 2019–BioTime, Inc. (NYSE American and TASE: BTX), a clinical-stage biotechnology company …

    Read More
  • 0 0